1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. North America Left Ventricular Assist Device Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. North America Left Ventricular Assist Device Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. North America Left Ventricular Assist Device Market Regional Analysis
6.2 North America Left Ventricular Assist Device Market Revenue 2020-2028 (US$ Million)
6.3 North America Left Ventricular Assist Device Market Forecast Analysis
7. North America Left Ventricular Assist Device Market Analysis – by Type of Flow
7.1 Pulsatile Flow
- 7.1.1 Overview
- 7.1.2 Pulsatile Flow: North America Left Ventricular Assist Device Market – Revenue and Forecast, 2020-2028 (US$ Million)
7.2 Non-Pulsatile Flow
- 7.2.1 Overview
- 7.2.2 Non-Pulsatile Flow: North America Left Ventricular Assist Device Market – Revenue and Forecast, 2020-2028 (US$ Million)
8. North America Left Ventricular Assist Device Market Analysis – by Design
8.1 Implantable Ventricular Assist Devices
- 8.1.1 Overview
- 8.1.2 Implantable Ventricular Assist Devices: North America Left Ventricular Assist Device Market – Revenue and Forecast, 2020-2028 (US$ Million)
8.2 Transcutaneous Ventricular Assist Devices
- 8.2.1 Overview
- 8.2.2 Transcutaneous Ventricular Assist Devices: North America Left Ventricular Assist Device Market – Revenue and Forecast, 2020-2028 (US$ Million)
9. North America Left Ventricular Assist Device Market Analysis – by Application
9.1 Bridge to Transplantation
- 9.1.1 Overview
- 9.1.2 Bridge to Transplantation: North America Left Ventricular Assist Device Market – Revenue and Forecast, 2020-2028 (US$ Million)
9.2 Destination Therapy
- 9.2.1 Overview
- 9.2.2 Destination Therapy: North America Left Ventricular Assist Device Market – Revenue and Forecast, 2020-2028 (US$ Million)
9.3 Bridge to Recovery
- 9.3.1 Overview
- 9.3.2 Bridge to Recovery: North America Left Ventricular Assist Device Market – Revenue and Forecast, 2020-2028 (US$ Million)
9.4 Bridge to Candidacy
- 9.4.1 Overview
- 9.4.2 Bridge to Candidacy : North America Left Ventricular Assist Device Market – Revenue and Forecast, 2020-2028 (US$ Million)
10. North America Left Ventricular Assist Device Market – North America Analysis
10.1 Overview
10.2 North America
- 10.2.1 North America Left Ventricular Assist Device Market Breakdown, by Key
Country, 2023 and 2028 (%)
- 10.2.1.1 North America Left Ventricular Assist Device Market – Revenue and
Forecast Analysis – by Country
- 10.2.1.1 US:
North America Left Ventricular Assist Device Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.1.1 US: North America Left Ventricular Assist Device Market Breakdown, by Type of Flow
- 10.2.1.1.2 US: North America Left Ventricular Assist Device Market Breakdown, by Design
- 10.2.1.1.3 US: North America Left Ventricular Assist Device Market Breakdown, by Application
- 10.2.1.2 Canada:
North America Left Ventricular Assist Device Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.2.1 Canada: North America Left Ventricular Assist Device Market Breakdown, by Type of Flow
- 10.2.1.2.2 Canada: North America Left Ventricular Assist Device Market Breakdown, by Design
- 10.2.1.2.3 Canada: North America Left Ventricular Assist Device Market Breakdown, by Application
- 10.2.1.3 Mexico :
North America Left Ventricular Assist Device Market – Revenue and Forecast to 2028 (US$ Million)
- 10.2.1.3.1 Mexico : North America Left Ventricular Assist Device Market Breakdown, by Type of Flow
- 10.2.1.3.2 Mexico : North America Left Ventricular Assist Device Market Breakdown, by Design
- 10.2.1.3.3 Mexico : North America Left Ventricular Assist Device Market Breakdown, by Application
11. Competitive Landscape
11.1 Heat Map Analysis
11.2 Company Positioning and Concentration
12. Industry Landscape
12.1 Overview
12.2 Market Initiative
12.3 Partnerships and Collaborations
12.4 Other Developments
13. Company Profiles
13.1 ABIOMED Inc
- 13.1.1 Key Facts
- 13.1.2 Business Description
- 13.1.3 Products and Services
- 13.1.4 Financial Overview
- 13.1.5 SWOT Analysis
- 13.1.6 Key Developments
13.2 Abbott Laboratories
- 13.2.1 Key Facts
- 13.2.2 Business Description
- 13.2.3 Products and Services
- 13.2.4 Financial Overview
- 13.2.5 SWOT Analysis
- 13.2.6 Key Developments
13.3 Medtronic Plc
- 13.3.1 Key Facts
- 13.3.2 Business Description
- 13.3.3 Products and Services
- 13.3.4 Financial Overview
- 13.3.5 SWOT Analysis
- 13.3.6 Key Developments
13.4 LivaNova Plc
- 13.4.1 Key Facts
- 13.4.2 Business Description
- 13.4.3 Products and Services
- 13.4.4 Financial Overview
- 13.4.5 SWOT Analysis
- 13.4.6 Key Developments
13.5 Terumo Corp
- 13.5.1 Key Facts
- 13.5.2 Business Description
- 13.5.3 Products and Services
- 13.5.4 Financial Overview
- 13.5.5 SWOT Analysis
- 13.5.6 Key Developments
13.6 Berlin Heart GmbH
- 13.6.1 Key Facts
- 13.6.2 Business Description
- 13.6.3 Products and Services
- 13.6.4 Financial Overview
- 13.6.5 SWOT Analysis
- 13.6.6 Key Developments
13.7 BiVACOR Inc
- 13.7.1 Key Facts
- 13.7.2 Business Description
- 13.7.3 Products and Services
- 13.7.4 Financial Overview
- 13.7.5 SWOT Analysis
- 13.7.6 Key Developments
13.8 Evaheart Inc
- 13.8.1 Key Facts
- 13.8.2 Business Description
- 13.8.3 Products and Services
- 13.8.4 Financial Overview
- 13.8.5 SWOT Analysis
- 13.8.6 Key Developments
13.9 BioVentrix Inc
- 13.9.1 Key Facts
- 13.9.2 Business Description
- 13.9.3 Products and Services
- 13.9.4 Financial Overview
- 13.9.5 SWOT Analysis
- 13.9.6 Key Developments
14. Appendix
14.1 About Business Market Insights
14.2 List of Abbreviations